DK3668516T3 - Stabile lyofilisater omfattende 5,10-methylen-(6r)-tetrahydrofolsyre og en dicarboxylsyre - Google Patents
Stabile lyofilisater omfattende 5,10-methylen-(6r)-tetrahydrofolsyre og en dicarboxylsyre Download PDFInfo
- Publication number
- DK3668516T3 DK3668516T3 DK18752161.2T DK18752161T DK3668516T3 DK 3668516 T3 DK3668516 T3 DK 3668516T3 DK 18752161 T DK18752161 T DK 18752161T DK 3668516 T3 DK3668516 T3 DK 3668516T3
- Authority
- DK
- Denmark
- Prior art keywords
- acid
- lyofilizates
- methylene
- stable
- dicarboxylic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
- C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/06—Oxalic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/145—Maleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17186518 | 2017-08-16 | ||
PCT/EP2018/072077 WO2019034673A1 (en) | 2017-08-16 | 2018-08-15 | STABLE LYOPHILISATES COMPRISING 5,10-METHYLENE- (6R) -TETRAHYDROFOLIC ACID AND DICARBOXYLIC ACID |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3668516T3 true DK3668516T3 (da) | 2021-12-13 |
Family
ID=59699495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK18752161.2T DK3668516T3 (da) | 2017-08-16 | 2018-08-15 | Stabile lyofilisater omfattende 5,10-methylen-(6r)-tetrahydrofolsyre og en dicarboxylsyre |
Country Status (11)
Country | Link |
---|---|
US (1) | US11337978B2 (da) |
EP (1) | EP3668516B1 (da) |
JP (1) | JP7232815B2 (da) |
KR (1) | KR20200041354A (da) |
CN (1) | CN110996958B (da) |
AU (1) | AU2018317789B2 (da) |
CA (1) | CA3073127A1 (da) |
DK (1) | DK3668516T3 (da) |
ES (1) | ES2902051T3 (da) |
PT (1) | PT3668516T (da) |
WO (1) | WO2019034673A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023237485A1 (en) | 2022-06-08 | 2023-12-14 | Merck Patent Gmbh | Stable lyophilisates comprising 5,10-methylene-(6r)-tetrahydrofolic acid |
WO2023237483A1 (en) | 2022-06-08 | 2023-12-14 | Merck Patent Gmbh | Concentrated solutions comprising 5,10-methylene-(6r)-tetrahydrofolic acid |
WO2023237484A1 (en) | 2022-06-08 | 2023-12-14 | Merck Patent Gmbh | Compositions comprising disodium 5,10-methylene-(6r)-tetrahydrofolate |
WO2023237482A1 (en) | 2022-06-08 | 2023-12-14 | Merck Patent Gmbh | Concentrated solutions comprising sodium 5,10-methylene-(6r)- tetrahydrofolate |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3483475D1 (de) | 1983-05-20 | 1990-11-29 | Bengt Gustavsson | Anordnung zur uebertragung einer substanz. |
US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
CH682664A5 (en) | 1991-10-15 | 1993-10-29 | Eprova Ag | Stable salts of 5,10-methylene tetrahydrofolate. |
CH684644A5 (de) | 1992-07-13 | 1994-11-15 | Eprova Ag | 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen. |
US20020103126A1 (en) | 1997-04-18 | 2002-08-01 | Roche Diagnostics Gmbh | Stable pharmaceutical form of administration for peptides, proteins and nucleic acids |
GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
CH696628A5 (de) * | 2002-02-26 | 2007-08-31 | Eprova Ag | Verwendung von Folaten zur Herstellung einer Zubereitung geeignet zur Vorbeugung und Behandlung von Entzündungen und entzündungsassoziierter Krankheiten, im Speziellen zur Beeinflussung der |
CH697021A5 (de) | 2003-06-26 | 2008-03-31 | Merck Eprova Ag | Stabile pharmazeutische Zusammensetzungen von 5, 10-Methylentetrahydrofolat. |
KR20080074201A (ko) * | 2005-12-02 | 2008-08-12 | 어드벤트륵스 파마슈티칼스, 인크. | 5,10 메틸렌테트라히드로폴레이트의 안정한 약학 조성물 |
MX342324B (es) | 2011-03-29 | 2016-09-23 | Sanofi Sa | Formulaciones de otamixaban con estabilidad mejorada. |
JP6235779B2 (ja) * | 2012-03-28 | 2017-11-22 | 株式会社コーセー | 葉酸含有組成物及び葉酸の安定化方法 |
EP2799061A1 (en) * | 2013-04-30 | 2014-11-05 | Aprofol AG | Stable high dose pharmaceutical composition containing folates |
EP2837631A1 (en) | 2013-08-14 | 2015-02-18 | Merck & Cie | New stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid |
CN104490887A (zh) | 2014-09-04 | 2015-04-08 | 连云港金康和信药业有限公司 | (6s)-5-甲基-四氢叶酸钙盐的稳定药物组合物 |
US10059710B2 (en) * | 2016-02-17 | 2018-08-28 | Merck & Cie | Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid |
-
2018
- 2018-08-15 US US16/638,528 patent/US11337978B2/en active Active
- 2018-08-15 PT PT187521612T patent/PT3668516T/pt unknown
- 2018-08-15 ES ES18752161T patent/ES2902051T3/es active Active
- 2018-08-15 EP EP18752161.2A patent/EP3668516B1/en active Active
- 2018-08-15 CA CA3073127A patent/CA3073127A1/en active Pending
- 2018-08-15 JP JP2020508004A patent/JP7232815B2/ja active Active
- 2018-08-15 CN CN201880052764.1A patent/CN110996958B/zh active Active
- 2018-08-15 KR KR1020207007389A patent/KR20200041354A/ko not_active Application Discontinuation
- 2018-08-15 DK DK18752161.2T patent/DK3668516T3/da active
- 2018-08-15 AU AU2018317789A patent/AU2018317789B2/en active Active
- 2018-08-15 WO PCT/EP2018/072077 patent/WO2019034673A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2020110073A3 (da) | 2022-01-24 |
ES2902051T3 (es) | 2022-03-24 |
EP3668516A1 (en) | 2020-06-24 |
JP7232815B2 (ja) | 2023-03-03 |
CA3073127A1 (en) | 2019-02-21 |
PT3668516T (pt) | 2021-12-23 |
AU2018317789B2 (en) | 2023-06-29 |
CN110996958B (zh) | 2023-05-12 |
KR20200041354A (ko) | 2020-04-21 |
WO2019034673A1 (en) | 2019-02-21 |
US20200368236A1 (en) | 2020-11-26 |
US11337978B2 (en) | 2022-05-24 |
EP3668516B1 (en) | 2021-09-22 |
JP2020531415A (ja) | 2020-11-05 |
CN110996958A (zh) | 2020-04-10 |
RU2020110073A (ru) | 2021-09-16 |
AU2018317789A1 (en) | 2020-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3668516T3 (da) | Stabile lyofilisater omfattende 5,10-methylen-(6r)-tetrahydrofolsyre og en dicarboxylsyre | |
DOP2017000280A (es) | Formas administración sólidas de palbociclib | |
SG11202010297UA (en) | Gip derivatives and uses thereof | |
DK3655401T3 (da) | Tlr7/8-antagonister og anvendelser deraf | |
DK3452463T3 (da) | Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf | |
DK3305785T3 (da) | Pyrido[3,4-d]pyrimidinderivat og farmaceutisk acceptabelt salt deraf | |
DK3615514T3 (da) | Propionsyre-derivater og deres anvendelsesformål | |
DK3612579T3 (da) | Pultrudat, fremstilling og anvendelse heraf | |
DK3653613T3 (da) | 1,3-disubstitueret ketenforbindelse og anvendelse deraf | |
DK3381601T3 (da) | Loddelegering, loddekugle og loddeforbindelse | |
DK3919498T6 (da) | Pyrrolopyrimidinderivat og anvendelse deraf | |
DK3634176T3 (da) | Møbelsokkel og møbel omfattende en sådan møbelsokkel | |
FR3032870B1 (fr) | Structure de mobilier repliable, en particulier de mobilier d'enseignement | |
DK3616765T3 (da) | Magnetisk konstruktionslegetøj | |
PT3384810T (pt) | Método para a produção de um painel de mobiliário | |
JP1704194S (ja) | スマートフォンおもちゃ | |
ES1229045Y (es) | Base rodante autoportante portacargas | |
ZA201807211B (en) | Knock-down bed base | |
JP1706053S (ja) | 人形 | |
JP1706054S (ja) | 人形 | |
JP1708698S (ja) | 人形 | |
TH2002005461S (th) | ตุ๊กตา | |
TH2002001500S (th) | ตุ๊กตา | |
TH2002001502S (th) | ตุ๊กตา | |
DOS2019000314S (es) | Juguetes |